LABU – Direxion Daily S&P Biotech Bull 3X Shares
Direxion Daily S&P Biotech Bull 3X Shares (LABU) is a Trading--Leveraged Equity ETF, issued by Direxion Funds, $587M in assets, 0.91% expense ratio.
Returns as of Oct 23, 2026: 1 week +10.4%, 1 year +93.3%.
Provides 3X daily leveraged exposure to S&P Biotech index. Invests in financial instruments tracking biotechnology sub-industry performance.
Top holdings
- MRNA – Moderna Inc, 0.5%
- NTRA – Natera Inc, 0.4%
- ABBV – AbbVie Inc, 0.4%
- HALO – Halozyme Therapeutics Inc, 0.4%
- BIIB – Biogen Inc, 0.4%
- AMGN – Amgen Inc, 0.4%
- UTHR – United Therapeutics Corporation, 0.4%
- EXEL – Exelixis Inc, 0.4%
- IOVA – Iovance Biotherapeutics Inc, 0.4%
- GILD – Gilead Sciences Inc, 0.3%
- TWST – Twist Bioscience Corp, 0.3%
- REGN – Regeneron Pharmaceuticals Inc, 0.3%
- SYRE – Spyre Therapeutics Inc., 0.3%
- VRTX – Vertex Pharmaceuticals Inc, 0.3%
- PTGX – Protagonist Therapeutics Inc, 0.3%
- PTCT – PTC Therapeutics Inc, 0.3%
- ALKS – Alkermes Plc, 0.3%
- KRYS – Krystal Biotech Inc, 0.3%
- ROIV – Roivant Sciences Ltd, 0.3%
- BBIO – BridgeBio Pharma Inc, 0.3%
- INCY – Incyte Corporation, 0.3%
- ORKA – Oruka Therapeutics, Inc., 0.3%
- TGTX – TG Therapeutics Inc, 0.3%
- ALNY – Alnylam Pharmaceuticals Inc, 0.3%
- RVMD – Revolution Medicines Inc, 0.3%